NEW YORK (77 WABC) — Results are in for trials on the drug hydroxychroloquine in New York. The head of the research team said it was inconclusive for the medicine that President Trump once touted as a possible miracle drug.
Patients who took Hydroxychroloquine, whether in conjunction with antibiotic azithromycin or not, were no more likely to survive their infections than those who did not, ABC7 said.
“We don’t see a statistically significant difference between patients who took the drugs and those who did not,” David Holtgrave, dean of the University at Albany School of Public Health, who conducted the study, told ABC.
On CNN Thursday night, Governor Cuomo said of the findings, “I think from the review that I heard basically it was not seen as a positive, not seen as a negative.”
The results have not yet been peer-reviewed or published. The study, sponsored by the state Department of Health, had 600 patients from 22 hospitals within New York City.